Serge Saxonov - 03 Aug 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
03 Aug 2021
Net transactions value
-$2,531,811
Form type
4
Filing time
04 Aug 2021, 16:48:46 UTC
Previous filing
08 Jul 2021
Next filing
25 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $26,248 +5,208 +0.58% $5.04* 909,276 03 Aug 2021 Direct F1
transaction TXG Class A Common Stock Options Exercise $112,412 +9,792 +1.1% $11.48 919,068 03 Aug 2021 Direct F1
transaction TXG Class A Common Stock Sale $300,085 -1,700 -0.18% $176.52 917,368 03 Aug 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $790,130 -4,450 -0.49% $177.56 912,918 03 Aug 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $1,418,127 -7,946 -0.87% $178.47 904,972 03 Aug 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $162,129 -904 -0.1% $179.35 904,068 03 Aug 2021 Direct F1, F5
holding TXG Class A Common Stock 89,960 03 Aug 2021 See Footnote F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -5,208 -6.6% $0.000000 74,157 03 Aug 2021 Class A Common Stock 5,208 $5.04 Direct F1, F7
transaction TXG Stock Option (right to buy) Options Exercise $0 -9,792 -13% $0.000000 67,921 03 Aug 2021 Class A Common Stock 9,792 $11.48 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $175.995 to $176.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $177.00 to $177.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $178.00 to $178.99. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $179.03 to $179.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F7 This option, originally for 250,000 shares, of which 175,843 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F8 This option, originally for 145,786 shares, of which 77,865 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.